BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced ...
Elevate your neurological research from initial discovery to diagnostics through consistent measurement of neurofilament light (NfL). The Quanterix Simoa® NfL assay is a highly sensitive laboratory ...
Vigil Neuroscience (VIGL) has made great progress in being able to advance its pipeline. It just reported interim results from its phase 2 IGNITE study, which used its drug iluzanebart [formerly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback